15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 18 firms covering Healthpeak Properties Inc, 5 rate it Buy or better, 13 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets span $17.00 to $24.00, a moderate spread. The average target of $20.68 sits 9% below the current $22.82. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 4 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.03 next quarter toward $-0.15 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS18 ratings
Hold
Strong Buy00%
Buy528%
Hold1372%
Sell00%
Strong Sell00%
Based on 18 analysts giving stock ratings to Healthpeak Properties Inc.
As of Jul, 5 of 18 firms rate DOC a Buy (13 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
DOC EPS & revenue forecast
EPS · NEXT QUARTER
$0.03
Range $0.01 – $0.07 · 7 analysts · -116% YoY
Next period, 7 analysts expect Healthpeak Properties Inc to earn $0.03 a share (range $0.01 – $0.07), versus $-0.17 a year earlier. Full-year consensus is $0.41, growing to $-0.15 the year after.
REVENUE · NEXT QUARTER
$729.6M
Range $689.0M – $758.3M · 7 analysts · +6% YoY
Revenue is expected to reach $729.6M (range $689.0M – $758.3M), +5.7% year-over-year. Full-year consensus is $2.9B, rising to $3.0B next year.
Top analysts covering Healthpeak Properties Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DOC.
#1
John Kilichowski
Wells Fargo
Hold
$22.00-3.6% to target
Coverage
—
+ Follow
#2
Nicholas Yulico
Scotiabank
Hold
$21.00-8.0% to target
Coverage
—
+ Follow
#3
JK
James Kammert
Evercore ISI Group
Hold
$21.00-8.0% to target
Coverage
—
+ Follow
#4
AS
Amanda Sweitzer
Baird
Buy
$21.00-8.0% to target
Coverage
—
+ Follow
#5
RH
Richard Hill
Morgan Stanley
Hold
$22.00-3.6% to target
Coverage
—
+ Follow
DOC stock forecast FAQ
What is DOC's average 12-month price target?+
The 16 analysts with a live target average $20.68 for Healthpeak Properties Inc over the next 12 months, ranging from a $24.00 high to a $17.00 low.
Is DOC stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 18 analyst ratings, 5 are Buy or Strong Buy, 13 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for DOC?+
The Street-high target is $24.00 (Mizuho), and the Street-low is $17.00 (Goldman Sachs). The average of all 16 active targets is $20.68.
How many Wall Street analysts cover DOC?+
18 analysts have an active rating on Healthpeak Properties Inc, and 16 firms carry a live 12-month price target.
Who is the most accurate analyst covering DOC?+
Among analysts who currently cover DOC, John Kilichowski of Wells Fargo has the strongest overall Quantellect track record. Their current call is Hold with a $22.00 target.
What is Healthpeak Properties Inc's projected EPS for next quarter?+
The consensus estimate is $0.03 per share (range $0.01 – $0.07) across 7 analysts. Full-year EPS is projected at $0.41, rising to $-0.15 the following year.
How much revenue is Healthpeak Properties Inc expected to report next quarter?+
Consensus revenue is $729.6M (range $689.0M – $758.3M). Full-year revenue is projected at $2.9B, growing to $3.0B next year.
Have analysts been upgrading or downgrading DOC lately?+
As of Jul, 5 of 18 firms rate DOC a Buy (13 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DOC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Raymond James
